Overview

Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed combination of calcipotriol and betamethason dipropionate, shall investigate in daily routine the efficacy, tolerability and changes in quality-of-life parameters in patients with scalp psoriasis
Details
Lead Sponsor:
LEO Pharma
Treatments:
Calcipotriene